Fig. 6.
Treatment with paclitaxel (Pacl) enhanced recruitment of nuclear factor-κB (NF-κB) p65 to the cx3cl1 gene promoter. Chromatin immunoprecipitation (ChIP) assays were performed with or without NF-κB p65 antibody. Increased recruitment of NF-κB p65 to the cx3cl1 gene promoter induced by paclitaxel was demonstrated by quantitative real-time polymerase chain reaction (A) and semiquantitative PCR (B). n = 7 in each group; **P < 0.01 vs. corresponding control group (Con). No Ab = normal immunoglobulin G without specific antibody.